Gingival mucormycosis: case report and literature review

Mucormycosis is a fungal infection with a high mortality rate (>50%) caused by the Mucorales often occurring in immunosuppressed patients, as with diabetes mellitus, hematopoietic stem cell transplants, or associated hematological malignancy. Mucormycosis usually develops as an acute infection and presents itself in rhinocerebral, pulmonary, gastrointestinal, cutaneous, and disseminated clinical types. Oral mucormycosis is rarely seen in clinical practice and reported cases are scarce [1-3]. Herein, we present the case of a male patient with L2 acute lymphoblastic leukemia (ALL) with gingival mucormycosis, as well as a short review of the literature.

[1]  H. Badali,et al.  Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. , 2019, The Lancet. Infectious diseases.

[2]  M. Korem,et al.  Successful Mandibular Mucormycosis Treatment in the Severely Neutropenic Patient. , 2019, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[3]  S. Watson,et al.  Mucor circinelloides induces platelet aggregation through integrin αIIbβ3 and FcγRIIA , 2019, Platelets.

[4]  T. Walsh,et al.  Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases , 2018, Medical mycology.

[5]  H. Ki,et al.  Oral mucormycosis in patients with haematologic malignancies in a bone marrow transplant unit , 2017, Mycoses.

[6]  F. Fonseca,et al.  Extensive Oral Mucormycosis in a Transplanted Patient. , 2017, The Journal of craniofacial surgery (Print).

[7]  J. Perfect,et al.  Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. , 2016, The Lancet. Infectious diseases.

[8]  K. Takemoto,et al.  Comparative study of the efficacy of liposomal amphotericin B and amphotericin B deoxycholate against six species of Zygomycetes in a murine lethal infection model , 2010, Journal of Infection and Chemotherapy.

[9]  M. Merino,et al.  Successful treatment of periodontal mucormycosis: report of a case and literature review. , 2010, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[10]  A. Bonifaz,et al.  Palatal zygomycosis: experience of 21 cases. , 2008, Oral diseases.

[11]  A. Auluck.  Maxillary necrosis by mucormycosis. a case report and literature review. , 2007, Medicina oral, patologia oral y cirugia bucal.

[12]  B. Antmen,et al.  Oral mucormycosis in children with leukemia: report of 2 cases. , 2007, Quintessence international.

[13]  D. Denning,et al.  Comparison of two fluorescent whiteners, Calcofluor and Blankophor, for the detection of fungal elements in clinical specimens in the diagnostic laboratory. , 2006, Clinical Microbiology and Infection.

[14]  D. Kontoyiannis,et al.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  B. Powell,et al.  Mucormycosis of the mandible after dental extractions in a patient with acute myelogenous leukemia. , 1997, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.